PDL241, a novel humanized monoclonal antibody, reveals CD319 as a therapeutic target for rheumatoid arthritis.
Woo J, Vierboom MP, Kwon H, Chao D, Ye S, Li J, Lin K, Tang I, Belmar NA, Hartman T, Breedveld E, Vexler V, 't Hart BA, Law DA, Starling GC.
Woo J, et al. Among authors: kwon h.
Arthritis Res Ther. 2013;15(6):R207. doi: 10.1186/ar4400.
Arthritis Res Ther. 2013.
PMID: 24299175
Free PMC article.